Comprehensive clinical drug information service: first year's experience

Healthcare professionals often require timely and accurate drug-related information to support clinical decisions. Prior research has shown that access to expert advice can improve patient outcomes and reduce medication errors. However, no prior work had resolved how to implement such a service on a regional scale. This gap motivated the establishment of a dedicated clinical drug information service. The Northern Region faced a growing need for drug information among hospital staff. Existing resources were insufficient to meet the demand for 24-hour access. No prior work had resolved the feasibility of a region-wide service. The service aimed to address this unmet need. It was unclear how different staff roles would utilize the service. The study sought to evaluate the first year's experience.

The study aimed to assess the usage patterns and effectiveness of a new clinical drug information service. The service was launched in the Northern Region in May 1975. It was staffed by clinical pharmacologists available around the clock. The primary goal was to provide accurate drug information to healthcare professionals. The researchers wanted to understand who used the service most. They also sought to determine the types of inquiries received. The service was designed to support clinical decision-making. The study focused on the first year of operation to evaluate early outcomes.

The service was staffed by eight clinical pharmacologists. It operated 24 hours a day in the Northern Region. Inquiries were recorded and categorized for analysis. The researchers tracked the number of consultative and non-consultative calls. They examined the roles of the individuals making the inquiries. Data was collected over a 12-month period. The service was available to all hospital staff in the region. The researchers analyzed the distribution of inquiry types and sources.

During the first year, the service received 451 inquiries. Of these, 354 were classified as consultative. Consultative inquiries accounted for 78.5% of the total. Junior hospital doctors made the most frequent inquiries. However, consultants contributed nearly half of the adverse reaction reports. The data showed a clear pattern in user roles and inquiry types. The service was accessed across all hours of operation. The results indicated a high demand for drug-related expert advice.

The service demonstrated high usage in its first year of operation. Junior doctors used it most frequently for general inquiries. Consultants contributed significantly to adverse reaction reports. The service met the need for 24-hour drug information access. The researchers noted the importance of role-specific inquiry patterns. The results suggest the service was well-received by hospital staff. The authors propose that such services can support safer medication use. They suggest further evaluation of long-term impact and expansion.